UNIGE document Scientific Article
previous document  unige:90428  next document
add to browser collection
Title

Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant

Authors
Ciulla, Thomas A
Harris, Alon
McIntyre, Nathaniel
Published in Expert Opinion on Pharmacotherapy. 2014, vol. 15, no. 7, p. 953-9
Abstract Diabetic macular edema (DME) can be treated with intravitreal glucocorticoids, particularly triamcinolone acetonide, dexamethasone (DEX), and fluocinolone acetonide (FA).
Keywords AnimalsDelayed-Action Preparations/chemistryDexamethasone/administration & dosage/therapeutic useDiabetic Retinopathy/complications/drug therapyDrug Implants/administration & dosage/therapeutic useFluocinolone Acetonide/administration & dosage/therapeutic useGlucocorticoids/administration & dosage/therapeutic useHumansIntravitreal InjectionsMacular Edema/complications/drug therapyTriamcinolone Acetonide/administration & dosage/therapeutic use
Identifiers
PMID: 24661081
Full text
Article (Published version) (410 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Ophtalmologie expérimentale (925)
Citation
(ISO format)
CIULLA, Thomas A et al. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant. In: Expert Opinion on Pharmacotherapy, 2014, vol. 15, n° 7, p. 953-9. https://archive-ouverte.unige.ch/unige:90428

75 hits

0 download

Update

Deposited on : 2016-12-15

Export document
Format :
Citation style :